Singapore: Vickers Venture leads $3.5m Series A into SiSaf

Singapore: Vickers Venture leads $3.5m Series A into SiSaf

Visual of SiSaf homepage. September 2016

Vickers Venture Partners, a venture capital (VC) firm with a global footprint, has announced a Series A investment of US$3.5 million along with Exen Capital into the next-gen silicon nanotechnology drug delivery company SiSafInvest Northern Ireland, an investor in earlier rounds, also followed on in this round.

The investment will be used to fund sales expansion in new markets and increase product research and development. The transaction will also see Dr Elkhalil Binebine, Vice Chairman at Vickers, and Eric Attias, Managing Partner at Exen Capital, will join SiSaf’s board of directors.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter